Dennis P. Schafer

FASgen, Inc. develops novel molecule therapeutics. It provides therapeutic applications for cancer, infectious diseases, and metabolic disorders including obesity and diabetes. The company was founded by James D. Dick, Frank P. Kuhajda, Albert H. Owens, and Craig A. Townsend in 2000 and is headquartered in Baltimore, MD.

Academy Funds is a family of venture capital funds located in Durham, North Carolina with an additional office in Greenville, South Carolina

Accuronix Therapeutics, Inc. develops novel therapies that selectively target cells and deliver cytotoxic payloads, thereby increasing efficacy and reducing toxicity risk. The firm also develops new class of drugs that work by selectively targeting the s-2 (sigma-2) receptor on cancer cells to deliver cytotoxic payloads. Its s-2 receptors are expressed on the surface of rapidly proliferating cancer cells. The company was founded by William Hawkins and Robert Mach and is headquartered in St. Louis, MO.

Altheus Therapeutics, Inc. developed novel therapies for inflammatory bowel diseases. It developed Zoenasa oral tablets and rectal gel formulations as novel front-line therapies for the treatment of ulcerative colitis and other inflammatory bowel diseases. The company was founded by William A. Hagstrom and Richard F. Harty in 2006 and was headquartered Oklahoma, OK.

FASgen LLC was engaged in pharmaceutical preparations. Its products are FAS-detect IHC and FAS-detect ELISA. The company was founded by Albert H. Owens Jr., Craig A. Townsend, James D. Dick and in 1999 and was headquartered in Baltimore, MD.

Curry Pharmaceuticals Corp. develops pharmaceutical products. It offers novel drugs for cancer, oncology, dermatology and other inflammatory diseases based on the natural product curcumin. The company was founded in 2003 by Dennis P. Schafer, Lowell A. Goldsmith, and Bharat Aggarwal and is headquartered in Durham, NC.

Secretech, Inc. is an American company that develops oral vaccines. Secretech was acquired by Zynaxis, Inc. on July 27, 1995 for $4.14 million.

ADERIS Pharmaceuticals, Inc. develops and commercializes drugs and pharmaceuticals. It engages in small molecule drug development to treat central nervous system, cardiovascular, and inflammatory disorders. The company was founded by Donald McAfee, Noel Cusack, Gevork I. Minaskanian, and Peter Savasand in 1994 and is headquartered in Hopkinton, MA.